Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. ADR (NQ: SNY )

48.67 -0.15 (-0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 838,711
Open 48.61
Bid (Size) 48.00 (2)
Ask (Size) 49.00 (1)
Prev. Close 48.82
Today's Range 48.31 - 48.67
52wk Range 42.63 - 55.72
Shares Outstanding 1,250,690,553
Dividend Yield 3.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Could Novavax Become the Next Moderna?
Sanofi believes in Novavax's vaccine strengths... 
Via The Motley Fool
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France,... 
Via Benzinga

Performance

YTD
-2.66%
-2.66%
1 Month
+5.55%
+5.55%
3 Month
+5.39%
+5.39%
6 Month
+3.51%
+3.51%
1 Year
-9.64%
-9.64%

More News

Read More
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
Via Benzinga
Is DoubleVerify’s 39% Haircut a Buying Opportunity?
Via MarketBeat
Topics Artificial Intelligence Fraud Malware
Exposures Artificial Intelligence Information Security Legal
Why Novavax Stock More Than Doubled Today
Via The Motley Fool
3 Stocks Under $2 That Can Trade in Double Digits by 2025
Via InvestorPlace
Novavax Stock Just Tripled. Is It Too Late to Buy?
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Cheap Biotech Stocks to Buy Now: May 2024
Via InvestorPlace
Exposures Product Safety
3 Meme Stocks That Are Likely to Crater in 2024
Via InvestorPlace
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024
From Fulcrum Therapeutics, Inc.
Via GlobeNewswire
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
From Fulcrum Therapeutics, Inc.
Via GlobeNewswire
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
Via InvestorPlace
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
Via InvestorPlace
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Via Investor's Business Daily
Exposures COVID-19
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
Via Benzinga
Exposures COVID-19
Why Is Novavax (NVAX) Stock Up 118% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
3 Biotech Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Via InvestorPlace
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.